2015
DOI: 10.4172/2329-6836.1000175
|View full text |Cite
|
Sign up to set email alerts
|

Camptothecin-Discovery, Clinical Perspectives and Biotechnology

Abstract: A historical account on discovery of camptothecin In 1955, National Cancer Institute (NCI) created a Cancer Chemotherapy National Service Center (CCNSC) for the evaluation for anticancer efficacy of potential compounds submitted by drug companies and institutions. Initially, CCNSC was screening chemically known structures and by 1960 they started to screen natural products of unknown chemical ingredients from plant and animal origin. The NCI plant program was led by Jonathan Hartwell, an eminent organic chemis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 84 publications
0
1
0
Order By: Relevance
“…The semi-synthetic derivatives of CPT, topotecan and irinotecan have been employed worldwide as clinical antitumor agents against lungs, cervix, ovaries, and colon cancers [3][4][5]. The annual CPT production by plants globally is only 600 kg; thus, it cannot meet the world market's estimated demand of about 3000 kg per year [6]. Despite the high demand for CPT for use in antitumor drugs, CPT has been extracted mainly from two arboreous plants, Camptotheca acuminata and Nothapodytes foetida (Olacaceae), which have a slow growth rate and low plant productivity and require wide cultivation area and high photosynthetic photon flux density (PPFD) [2,7].…”
Section: Introductionmentioning
confidence: 99%
“…The semi-synthetic derivatives of CPT, topotecan and irinotecan have been employed worldwide as clinical antitumor agents against lungs, cervix, ovaries, and colon cancers [3][4][5]. The annual CPT production by plants globally is only 600 kg; thus, it cannot meet the world market's estimated demand of about 3000 kg per year [6]. Despite the high demand for CPT for use in antitumor drugs, CPT has been extracted mainly from two arboreous plants, Camptotheca acuminata and Nothapodytes foetida (Olacaceae), which have a slow growth rate and low plant productivity and require wide cultivation area and high photosynthetic photon flux density (PPFD) [2,7].…”
Section: Introductionmentioning
confidence: 99%